Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.37M Buy
+20,406
New +$1.36M 0.03% 896
2025
Q4
Sell
-50,185
Closed -$3.38M 1654
2025
Q3
$3.38M Buy
+50,185
New +$3.97M 0.08% 352
2025
Q2
Sell
-30,282
Closed -$2.07M 1712
2025
Q1
$2.07M Buy
30,282
+13,698
+83% +$1.12M 0.14% 184
2024
Q4
$1.29M Sell
16,584
-47,164
-74% -$3.49M 0.09% 331
2024
Q3
$4.27M Buy
63,748
+57,427
+909% +$4.72M 0.26% 65
2024
Q2
$717K Buy
6,321
+1,583
+33% +$200K 0.04% 653
2024
Q1
$657K Buy
+4,738
New +$596K 0.05% 572
2023
Q4
Sell
-25,582
Closed -$2.39M 1329
2023
Q3
$2.39M Buy
25,582
+14,336
+127% +$1.62M 0.23% 106
2023
Q2
$1.45M Buy
11,246
+4,910
+77% +$594K 0.15% 175
2023
Q1
$736K Sell
6,336
-12,154
-66% -$1.36M 0.09% 359
2022
Q4
$2.09M Buy
+18,490
New +$2.03M 0.31% 51
2022
Q1
Sell
-9,800
Closed -$1.32M 778
2021
Q4
$1.32M Buy
+9,800
New +$1.41M 0.31% 72

Other funds holding DXCM

Y-Intercept (HK)'s DXCM Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in DexCom (DXCM) in Q2 2026: 20,406 shares worth $1.37M. The stake represents 0.03% of the portfolio and ranks #896 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in DXCM as recently as Q3 2025.

Y-Intercept (HK) first reported a position in DXCM in Q4 2021 and has held it in 12 quarters since. The position peaked at $4.27M in Q3 2024. 225 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Y-Intercept (HK) held 20,406 shares of DexCom worth $1.37M as of Q2 2026.
  • DexCom was a new Y-Intercept (HK) position in Q2 2026.
  • DexCom made up 0.03% of Y-Intercept (HK)'s portfolio in Q2 2026, its #896 holding.
  • Y-Intercept (HK) first reported a position in DexCom in Q4 2021 and has held it in 12 quarters since.
  • Y-Intercept (HK)'s DexCom position peaked at $4.27M in Q3 2024.
  • 225 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.